Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...

Biomarker testing in non-small cell lung cancer is underutilized, hindering optimal treatment. Streamlined processes and ...

Cancer is often caused by genetic mutations, which can lead to abnormal cell growth in the body. One type is called the KRAS G12C mutation, which happens in the KRAS protein.[1] KRAS acts as the ...

A panel held during the Institute for Value-Based Medicine event in Chicago on August 14, 2025, included discussions of access to biomarker testing and perioperative treatment in patients with ...

Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) examined the pros and cons of biomarker-based tests to inform decisions about adjuvant chemotherapy for patients with a certain ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

After gaining momentum last session, cancer care advocates returned to Beacon Hill Tuesday to promote bills expanding access to biomarker testing, which can help oncology providers determine targeted ...

Testing that can help with the early detection and treatment of diseases including cancer, Alzheimer’s and multiple sclerosis will be accessible to more patients soon. Right now, health insurance ...